Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov-Dec;33(6):1406-1411.
doi: 10.12669/pjms.336.13631.

Clinical analysis of Primary Gastrointestinal Non-Hodgkin's Lymphoma

Wei Wang  1 , Peng Lin  2 , Haiying Yao  3 , Xi Jia  4 , Jirui Sun  5
Affiliations

Clinical analysis of Primary Gastrointestinal Non-Hodgkin's Lymphoma

Wei Wang et al. Pak J Med Sci. 2017 Nov-Dec.

Abstract

Objective: To study the clinical characteristics and prognostic factors of survival for patients with primary gastrointestinal non-Hodgkin's lymphoma (PGI-NHL).

Methods: A retrospective analysis was performed for 104 PGI-NHL patients who were admitted in Baoding First Central Hospital from July 2003 to January 2014.

Results: There were 58 males and 46 females. The median age of onset was 53 (15-83) years old. In terms of pathogenic sites, there were 51 gastric cases (49.00%) and 53 intestinal cases (51.00%), with the median survival of 35 (1-130) months. The 1-, 3- and 5-year overall survival (OS) rates were 88.40%, 80.70% and 78.80%, respectively. The factors influencing the progression-free survival (PFS) and OS rates were studied by univariate and multivariate analyses. The PFS and OS rates of patients with B-cell PGI-NHL were significantly higher than those of patients with T-cell PGI-NHL (P<0.05). The PFS and OS rates of patients with primary gastric lymphoma were significantly higher than those of patients with primary intestinal lymphoma (P<0.05), but the data were not associated with Ann Arbor stage or LDH level (P>0.05). Compared with non-surgical patients, only patients with intestinal lymphoma benefited from surgery (P<0.05).

Conclusion: The pathogenic site and pathological type are risk factors that affect the survival of PGI-NHL patients, and chemotherapy should be given the first priority for patients with primary gastric lymphoma.

Keywords: Gastrointestinal tract; Prognosis; non-Hodgkin’s lymphoma.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: None.

Figures

Fig.1
Fig.1
PFS (a) and OS (b) of PGI-NHL patients at different pathogenic sites.
See this image and copyright information in PMC

References

    1. Uppenkamp M, Feller AC. Classification of malignant lymphoma. Onkologie. 2002;25(6):563–570. doi:68629. - PubMed
    1. Velickovic D, Sabljak P, Ebrahimi K, Bjelovic M, Stojakov D, Nenadic B, et al. Upper gastrointestinal bleeding as a surgical comp lication of primary gastric lymphoma. Acta Chir Jugosl. 2013;54(1):131–134. - PubMed
    1. Guo R, Ye X, Pang Y, Feng Y. A Spleen Primary non-Hodgkin Lymphoma Example Report and Literature Review. Chin J Thromb Hemost. 2011;17(1):33–35.
    1. Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer. 1999;79(11-12):1929–1934. - PMC - PubMed
    1. Wei TS. Diagnostic value of multi-slice spiral CT in primary intestinal lymphoma. Shanxi Med J. 2014;43(15):1791–1793.

LinkOut - more resources